CLEARPOINT NEURO, INC.

CLEARPOINT NEURO, INC. specializes in the design and manufacturing of advanced neurosurgical workstations and precision medical devices for clinical use, with a focus on integrating real-time navigation, imaging, and robotic-assisted technologies to enhance surgical accuracy in minimally invasive procedures. Their technical expertise lies in developing FDA-regulated Class II medical systems that combine hardware, embedded software, and clinical user interfaces to support neurointerventional workflows, particularly in stereotactic and electrophysiological applications. The company’s key differentiator is its ability to engineer integrated workstations that synchronize intraoperative data streams with preoperative imaging, enabling clinicians to perform high-precision brain procedures with enhanced safety and repeatability. The contractor has delivered solutions exclusively to the Department of Veterans Affairs, indicating a focused relationship with veteran healthcare systems that prioritize neurosurgical innovation and clinical efficiency. Their work supports VA medical centers in modernizing neurointerventional capabilities, likely aligning with VA’s strategic goals for advanced neurological care and veteran-centered surgical outcomes. Operating under NAICS 339113, CLEARPOINT NEURO, INC. is positioned within the surgical appliance and supplies manufacturing sector, specializing in Class II medical devices that require rigorous validation, regulatory compliance, and clinical integration. Their market niche is the intersection of neurosurgical technology and clinical workflow automation, serving hospitals and specialized care facilities requiring precision-guided intervention systems. As a small business structured as a 2L entity based in Carlsbad, California, CLEARPOINT NEURO, INC. maintains a focused geographic footprint with no federal certifications disclosed. Their government market presence is defined by direct delivery of high-complexity medical devices to federal healthcare providers, emphasizing regulatory adherence and clinical utility over broad-scale procurement volume.